These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 7969965

  • 21. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study.
    Scrima L, Hartman PG, Johnson FH, Thomas EE, Hiller FC.
    Sleep; 1990 Dec; 13(6):479-90. PubMed ID: 2281247
    [Abstract] [Full Text] [Related]

  • 22. Effects of oral L-carnitine administration in narcolepsy patients: a randomized, double-blind, cross-over and placebo-controlled trial.
    Miyagawa T, Kawamura H, Obuchi M, Ikesaki A, Ozaki A, Tokunaga K, Inoue Y, Honda M.
    PLoS One; 2013 Dec; 8(1):e53707. PubMed ID: 23349733
    [Abstract] [Full Text] [Related]

  • 23. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
    Weinhold SL, Seeck-Hirschner M, Nowak A, Hallschmid M, Göder R, Baier PC.
    Behav Brain Res; 2014 Apr 01; 262():8-13. PubMed ID: 24406723
    [Abstract] [Full Text] [Related]

  • 24. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ.
    Rev Neurol; 2014 Apr 01; 48(1):27-31. PubMed ID: 19145563
    [Abstract] [Full Text] [Related]

  • 25. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
    Nakamura M, Kanbayashi T, Sugiura T, Inoue Y.
    J Sleep Res; 2011 Mar 01; 20(1 Pt 1):45-9. PubMed ID: 20642748
    [Abstract] [Full Text] [Related]

  • 26. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials.
    Boscolo-Berto R, Viel G, Montagnese S, Raduazzo DI, Ferrara SD, Dauvilliers Y.
    Sleep Med Rev; 2012 Oct 01; 16(5):431-43. PubMed ID: 22055895
    [Abstract] [Full Text] [Related]

  • 27. Simultaneous MAO-B and COMT inhibition in L-Dopa-treated patients with Parkinson's disease.
    Lyytinen J, Kaakkola S, Ahtila S, Tuomainen P, Teräväinen H.
    Mov Disord; 1997 Jul 01; 12(4):497-505. PubMed ID: 9251066
    [Abstract] [Full Text] [Related]

  • 28. Reversal of atypical depression, sleepiness, and REM-sleep propensity in narcolepsy with bupropion.
    Rye DB, Dihenia B, Bliwise DL.
    Depress Anxiety; 1998 Jul 01; 7(2):92-5. PubMed ID: 9614600
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Ritanserin, a 5-HT2 receptor blocker, as add-on treatment in narcolepsy.
    Lammers GJ, Arends J, Declerck AC, Kamphuisen HA, Schouwink G, Troost J.
    Sleep; 1991 Apr 01; 14(2):130-2. PubMed ID: 1678203
    [Abstract] [Full Text] [Related]

  • 31. Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder?
    Baumann C, Ferini-Strambi L, Waldvogel D, Werth E, Bassetti CL.
    J Neurol; 2005 Feb 01; 252(2):139-45. PubMed ID: 15729517
    [Abstract] [Full Text] [Related]

  • 32. Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy.
    Bogan RK, Feldman N, Emsellem HA, Rosenberg R, Lu Y, Bream G, Khayrallah M, Lankford DA.
    Sleep Med; 2015 Sep 01; 16(9):1102-8. PubMed ID: 26298786
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J, Swick T, Bogan R, Lai C, Carter LP.
    Sleep Med; 2016 Aug 01; 24():57-62. PubMed ID: 27810187
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Sodium oxybate in narcolepsy with cataplexy: Zurich sleep center experience.
    Poryazova R, Tartarotti S, Khatami R, Baumann CR, Valko P, Kallweit U, Werth E, Bassetti CL.
    Eur Neurol; 2011 Aug 01; 65(3):175-82. PubMed ID: 21389728
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.